Articles & Video
Andreas Diacon, TASK Applied Science, announced as winner of Christine Pierre Lifetime Achievement Award 2019
At this year's Clinical Trials Europe, the Christine Pierre Lifetime Achievement Award 2019 was presented to Andreas Diacon, Founder, Director and & CEO at TASK Applied Science.
Life Sciences in 2020: Predictions from industry insiders
Industry insiders predict how life sciences will change in 2020 in emerging therapies, clinical trials, regulations and agriculture.
The Top 10 Posts of 2019: Clinical Trials Innovation
We look back at 2019's most popular articles on innovating clinical trials in an interactive flip-book.
Pharma’s pivotal role in social determinants of health
Pharma manufacturers have a pivotal role to play in precision population health through strategic data collection, analysis, and biopsychosocial and algorithmic interventions to address SDOH.
CRO oversight: 6 things to consider when selecting a vendor
What must a clinical trial sponsor look for in choosing a CRO? Here's a checklist of 6 important things.
The Pain Clinic with Kate O'Brien
Discover the most common issues facing clinical trials, and potential solutions in this interactive flipbook from site consultant Kate O'Brien.
Real World Evidence in clinical trials: 3 case studies of successful implementation
Using Real World Evidence in clinical trials has huge potential, but also faces many hurdles - we look at 3 successful case studies.
Accelerating Alzheimer’s dementia research with collaborative research design
Katrin Haeverans at Janssen presents a case study of large-scale collaborative research design being used to revolutionize studies into Alheimer's dementia.
11 ways clinical trial protocol design can improve speed and costs
We look at 11 different opportunities to improve speed and cost of clinical trials by taking into consideration both protocol designs and contextual variables such as collaborations.
A clinical trial investigator's insider view
Site consultant Kate O’Brien speaks to two clinical trial investigators and a research nurse about the challenges facing sites today.
3 case studies for implementing wearables in clinical trials
We look at three case studies of how wearables are being used in clinical trials and try to separate reality from hype.
10 predictions for clinical trials in 2020 - INDUSTRY VOICES
We asked 10 clinical trial insiders their predictions for how clinical trials will most change in 2020.
How can the success of clinical partnerships be measured? - INDUSTRY VOICES
We asked five industry experts which metrics can be measured to judge the success of clinical partnerships.
How close are we to fully virtual oncology clinical trials?
What steps still need to be taken to implement virtual clinical trials in oncology?
How clinical trial Principal Investigators can maintain oversight
How can Principal Investigators maintain clinical trial oversight and delegate staff roles? Site consultant Kate O’Brien offers some advice.
The single technology that will have the biggest impact on clinical trials - INDUSTRY VOICES
We ask seven clinical trials experts which single technology they think will have the biggest impact on clinical trials.
How far can we trust AI in clinical trials?- INDUSTRY VOICES
Seven industry experts tell us what they see as the greatest challenges in using AI in clinical trials and how they can best be solved.
Virtual trials and Real World Evidence: The global shift in clinical operations
We deep-dive into our State of the Industry Report 2019 to understand how companies are utilizing virtual trials and Real World Evidence in their clinical trial operations.
The operational challenges facing virtual clinical trials - INDUSTRY VOICES
Virtual clinical trials face a number of operational challenges before they can be fully and effectively implemented. We ask five industry insiders about how to overcome them.
Outsourcing in clinical trials: an EU struggle? - Data report analysis
In a recent report, we investigated what today’s clinical trials professionals see as the biggest risks faced in managing relationships with third-party organisations.